NIAID Awards Zepto Life Technology Contract Valued at Up to $8.9 Million to Advance the First Deployable Liquid Biopsy Platform for Infectious Disease

Summary

Zepto Life Technology received an $8.9 million contract from NIAID to advance FungiFlex, a deployable liquid biopsy platform for infectious diseases, through clinical validation and planned FDA submission. The award covers engineering, manufacturing, and development phases.